Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ELANTAS Beck IndiaBOM:500123 +0.75%84 EBITDA Margin % is 20.84% as of Mar. 2026, which is 12% below its 10-year median of 23.59. GuruFocus rates BOM:500123 with a GF Score™ of 84/100 and a GF Value™ of ₹11,100.45 (Modestly Undervalued). Among 1,578 Chemicals companies, ELANTAS Beck India ranks better than 90.62% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. ELANTAS Beck India's EBITDA for the
three
months ended in Mar. 2026 was ₹463 Mil. ELANTAS Beck India's Revenue for the
three
months ended in Mar. 2026 was ₹2,222 Mil. Therefore, ELANTAS Beck India's EBITDA margin for the quarter that ended in Mar. 2026 was 20.84%.
ELANTAS Beck India (BOM:500123) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
ELANTAS Beck India EBITDA Margin % Related Terms
ELANTAS Beck India EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for ELANTAS Beck India's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:500123 vs LIN, SHW, ECL: EBITDA Margin % Comparison
For the Specialty Chemicals subindustry, ELANTAS Beck India's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ELANTAS Beck India EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, ELANTAS Beck India's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where ELANTAS Beck India's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ELANTAS Beck India (BOM:500123) has a EBITDA Margin % of 20.84% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on ELANTAS Beck India and its competitors. This is 12% below median its historical median of 23.59. Over the past decade, ELANTAS Beck India's EBITDA Margin % has ranged from 18.21 to 29.04. According to the industry distribution chart, ELANTAS Beck India ranks #148 out of 1578 companies in the Chemicals industry, placing it in the top 9.4%.
Is ELANTAS Beck India's EBITDA Margin % too high?
ELANTAS Beck India's current EBITDA Margin % of 20.84% is 12% below median its 10-year median of 23.59. Over the past 10 years, this metric has ranged from a low of 18.21 to a high of 29.04. The Chemicals industry median EBITDA Margin % is 9.64. ELANTAS Beck India's value of 20.84% is 116.3% above this industry median. Based on the distribution chart, ELANTAS Beck India ranks #148 out of 1578 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, ELANTAS Beck India has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ELANTAS Beck India's EBITDA Margin % compare to LIN and SHW?
According to the Chemicals industry distribution chart, ELANTAS Beck India ranks #148 out of 1578 companies for EBITDA Margin %. This places ELANTAS Beck India in the top 9% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 9.64. ELANTAS Beck India's value of 20.84% is 116.3% above this benchmark. Historically, ELANTAS Beck India's own EBITDA Margin % has ranged from 18.21 to 29.04 over the past decade. While the company's 10-year median is 23.59 vs. the industry median of 9.64, ELANTAS Beck India has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.64, based on 1,578 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ELANTAS Beck India's current EBITDA Margin % of 20.84% is 116.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on ELANTAS Beck India and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ELANTAS Beck India's current EBITDA Margin % is 20.84%, which is 12% below median its own 10-year median of 23.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ELANTAS Beck India stock overvalued right now?
Based on GuruFocus' analysis, ELANTAS Beck India (BOM:500123) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹11,100.45, compared to a current price of ₹9,273.55 — trading 16.5% below its estimated fair value. The current EBITDA Margin % is 20.84%, which is 12% below median its 10-year median of 23.59 and 116.3% above the Chemicals industry median of 9.64. ELANTAS Beck India's overall GF Score™ is 84/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For ELANTAS Beck India (BOM:500123), the current EBITDA Margin % is 20.84% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ELANTAS Beck India (BOM:500123) Overvalued in 2026?
Based on GuruFocus' analysis, ELANTAS Beck India stock appears to be undervalued.
The current stock price of ₹9,273.55 is trading 16.5% below its estimated GF Value™ of ₹11,100.45.
GuruFocus considers ELANTAS Beck India to be Modestly Undervalued.
Key valuation signals for BOM:500123:
EBITDA Margin %: 20.84% (12% below median its 10-year median of 23.59)
GF Value™: ₹11,100.45 vs. price of ₹9,273.55 (16.5% below fair value)
Industry Position: 116.3% above the Chemicals median (#148 of 1578)
No single metric tells the full story. See the BOM:500123 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ELANTAS Beck India Ltd manufactures a wide range of specialty chemicals for electrical insulation and construction industries, which includes Primary Insulation, Secondary Insulation and Electronic & Engineering Materials. It offers a broad portfolio of wire enamels, impregnating resins and varnishes, casting & potting materials, flexible electrical insulation materials, conformal coatings as well as adhesives & sealants fulfilling the requirements of technical and environmental standards. Its segments include Electrical Insulations, which comprises three product groups: wire enamels, insulating varnishes & resins, and casting & potting compounds.; Engineering & Electronic Resins solutions, and Materials comprises of complete solutions for printed circuit boards (PCBs).
84GF Score
Get the complete analysis for BOM:500123
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:500123 has been successfully added to your 
